Clusterin Expression in Adult Human Normal and Osteoarthritic Articular Cartilage
Overview
Rheumatology
Affiliations
Objective: To characterize the expression pattern of clusterin in adult human normal and osteoarthritic cartilage.
Methods: Clusterin mRNA expression in adult human normal and osteoarthritic cartilage was investigated by analysis of cDNA libraries, TaqMan quantitative RT-PCR, microarray and in situ hybridization.
Results: Sequence analysis of ESTs from adult human normal and osteoarthritic cartilage cDNA libraries demonstrated that the abundance of clusterin in these libraries was equivalent to genes which have been more commonly associated with cartilage. To examine tissue distribution, TaqMan Quantitative PCR analysis was performed using RNA from a panel of individual normal tissues. Clusterin was expressed at significant levels in cartilage, brain, liver, and pancreas. The expression of clusterin mRNA was up-regulated in early osteoarthritic vs normal cartilage when analysed by microarray analysis. Using in situ hybridization, chondrocytes of normal cartilage expressed moderate levels of clusterin. Upper mid-zone chondrocytes in cartilage with early stages of osteoarthritic disease expressed high levels of clusterin mRNA. In advanced osteoarthritic cartilage, the overall expression of clusterin was reduced.
Conclusion: The induction of clusterin has been associated with a variety of disease states where it appears to provide a cytoprotective effect. The increased expression of clusterin mRNA in the early stages of osteoarthritis (OA) may reflect an attempt by the chondrocytes to protect and repair the tissue. In contrast, the decrease in clusterin mRNA in the advanced osteoarthritic cartilage accompanies the final degenerative stages of the disease. An understanding of the expression of clusterin in osteoarthritis may allow consideration of this protein as a marker for cartilage changes in this chronic degenerative condition.
Clusterin: structure, function and roles in disease.
Du X, Chen Z, Shui W Int J Med Sci. 2025; 22(4):887-896.
PMID: 39991767 PMC: 11843140. DOI: 10.7150/ijms.107159.
Ungsudechachai T, Jittikoon J, Honsawek S, Udomsinprasert W Clin Transl Sci. 2024; 17(7):e13881.
PMID: 38982592 PMC: 11233271. DOI: 10.1111/cts.13881.
Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis.
Ng J, Jafarov T, Little C, Wang T, Ali A, Ma Y Nat Commun. 2023; 14(1):6909.
PMID: 37907525 PMC: 10618187. DOI: 10.1038/s41467-023-42199-1.
Hulme C, Peffers M, Roberts S, Gallacher P, Jermin P, Wright K Am J Sports Med. 2023; 51(6):1422-1433.
PMID: 37039559 PMC: 10155277. DOI: 10.1177/03635465231156616.
The therapeutic and prognostic role of clusterin in diverse musculoskeletal diseases: a mini review.
Zhang K, Liu K, Yu D, Tang Y, Geng B, Xia Y Physiol Res. 2022; 71(6):739-747.
PMID: 36281729 PMC: 9814988.